UncategorizedNew Releases from NCBI BookshelfMogamulizumab for previously treated mycosis fungoides and Sézary syndrome.Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfMetreleptin for treating lipodystrophy.Metreleptin for treating lipodystrophy. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfAgency Issue Paper: Use of New Approach Methodologies to Derive Extrapolation Factors and Evaluate Developmental Neurotoxicity for Human Health Risk Assessment.Agency Issue Paper: Use of New Approach Methodologies to Derive Extrapolation Factors and Evaluate Developmental Neurotoxicity for Human Health Risk Assessment. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfGivosiran for treating acute hepatic porphyria.Givosiran for treating acute hepatic porphyria. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfNivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer.Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfOlaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal).Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal). Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfMexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders.Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfDupilumab for treating severe asthma with type 2 inflammation.Dupilumab for treating severe asthma with type 2 inflammation. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfBelimumab for treating active autoantibody-positive systemic lupus erythematosus.Belimumab for treating active autoantibody-positive systemic lupus erythematosus. Leave a Comment / Uncategorized / admin Post Content
UncategorizedNew Releases from NCBI BookshelfNintedanib for treating progressive fibrosing interstitial lung diseases.Nintedanib for treating progressive fibrosing interstitial lung diseases. Leave a Comment / Uncategorized / admin Post Content